Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics (LENZ) Capital Expenditures: 2020-2024

Historic Capital Expenditures for Therapeutics (LENZ) over the last 5 years, with Dec 2024 value amounting to $468,000.

  • Therapeutics' Capital Expenditures fell 98.27% to $24,000 in Q2 2023 from the same period last year, while for Jun 2023 it was $2.0 million, marking a year-over-year change of. This contributed to the annual value of $468,000 for FY2024, which is 1460.00% up from last year.
  • Therapeutics' Capital Expenditures amounted to $468,000 in FY2024, which was up 1,460.00% from $30,000 recorded in FY2023.
  • Therapeutics' Capital Expenditures' 5-year high stood at $6.6 million during FY2022, with a 5-year trough of $30,000 in FY2023.
  • In the last 3 years, Therapeutics' Capital Expenditures had a median value of $468,000 in 2024 and averaged $2.4 million.
  • In the last 5 years, Therapeutics' Capital Expenditures plummeted by 99.55% in 2023 and then spiked by 1,460.00% in 2024.
  • Over the past 5 years, Therapeutics' Capital Expenditures (Yearly) stood at $1.5 million in 2020, then soared by 271.52% to $5.7 million in 2021, then grew by 14.88% to $6.6 million in 2022, then crashed by 99.55% to $30,000 in 2023, then soared by 1,460.00% to $468,000 in 2024.